Applicability of the PAINESD risk score for 30-day mortality prediction post ventricular tachycardia catheter ablation in Chagas disease

Autor: R M, Kulchetscki, C F, Pisani, F K B, Alexandre, M P, Mayrink, A P, Ferraz, F C, Gouvea, A L M, Goncalves, C A, Hardy, S L, Melo, M O, Chokr, M I, Scanavacca

Publikováno v: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 62(3)

The PAINESD risk score was developed in 2015 as a tool to stratify the risk of acute hemodynamic decompensation during ventricular tachycardia (VT) ablation in structural heart disease patients and further then used for post procedure 30-day mortalit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aab0b71ae107ec5b57506db565d23464
https://pubmed.ncbi.nlm.nih.gov/33963500

[Relationship between conduction persistence through the slow pathway after atrioventricular nodal reentry tachycardia radiofrequency ablation and its recurrence]

Autor: M A, Silva, M I, Scanavacca, A, D'Avila, R, Kuniyoshi, E A, Sosa

Publikováno v: Arquivos brasileiros de cardiologia. 71(2)

The aim of this study is to verify whether the persistence of conduction over the slow pathway is related to an increased trend for recurrence.Recurrence rate was retrospectively analyzed in 126 patients who underwent slow pathway radiofrequency (RF)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a636a59b67223034556a68a8299cbed6
https://pubmed.ncbi.nlm.nih.gov/9816682

[The surgical treatment of nodal reentry tachycardia. The late results]

Autor: M I, Scanavacca, E, Sosa, M B, Marcial, F M, Consolim, L M, Sabbag, G, Bellotti, F, Pileggi

Publikováno v: Arquivos brasileiros de cardiologia. 59(2)

To analyze the long-term results of surgical treatment of atrioventricular nodal reentrant tachycardia (AVNT).From March 1987 to March 1990, 20 patients with AVNT were submitted to surgical therapy, 14 female, aged 12 to 70 (42.8 +/- 17) years. All p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e441bb55ecd1850076d1124d9b4755a4
https://pubmed.ncbi.nlm.nih.gov/1341166

Tanshinone IIA potentiates the chemotherapeutic effect of doxorubicin against breast cancer cells and attenuates the cardiotoxicity of doxorubicin by regulating ERK1/2 pathway.

Autor: Li S; Department of Emergency Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China., FeiyuTeng; Department of Clinical Laboratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China., Zhang J; Department of Clinical Laboratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China., Zhang P; Department of Clinical Laboratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China., Li M; Department of Clinical Laboratory, Jinzhou Women and Children's Hospital, Jinzhou, China., Wang X; Department of Clinical Laboratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China., Li K; Department of Clinical Laboratory, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

Publikováno v: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Oct; Vol. 38 (10), pp. e23851.

Applicability of the PAINESD risk score for 30-day mortality prediction post ventricular tachycardia catheter ablation in Chagas disease.

Autor: Kulchetscki, R. M., Pisani, C. F., Alexandre, F. K. B., Mayrink, M. P., Ferraz, A. P., Gouvea, F. C., Goncalves, A. L. M., Hardy, C. A., Melo, S. L., Chokr, M. O., Scanavacca, M. I.

Publikováno v: Journal of Interventional Cardiac Electrophysiology; Dec2021, Vol. 62 Issue 3, p469-477, 9p